<DOC>
	<DOC>NCT00692874</DOC>
	<brief_summary>This is an open label, non-interventional quality of life analysis for Zoladex treated prostate cancer patients by investigator's questionnaire</brief_summary>
	<brief_title>Quality of Life Analysis of Treatment in Patients With Prostate Cancer on Adjuvant Zoladex Therapy</brief_title>
	<detailed_description />
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<criteria>Provision of informed consent Early or locallyadvanced prostate cancer patients on androgen deprivation therapy Investigators are requested to recruit patients only with at least 1 month prior Zoladex treatment. Allergy to substance of medication Prostate cancer patients with advanced disease</criteria>
	<gender>Male</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2010</verification_date>
	<keyword>Quality of Life</keyword>
</DOC>